Adult neurogenesis in the subventricular zone of the lateral ventricle decreases with age. In the subventricular zone, the specialized extracellular matrix structures, known as fractones, contact neural stem cells and regulate neurogenesis. Fractones are composed of extracellular matrix components, such as heparan sulfate proteoglycans. We previously found that fractones capture and store fibroblast growth factor 2 (FGF-2) via heparan sulfate binding, and may deliver FGF-2 to neural stem cells in a timely manner. The heparan sulfate (HS) chains in the fractones of the aged subventricular zone are modified based on immunohistochemistry. However, how aging affects fractone composition and subsequent FGF-2 signaling and neurogenesis remains unknown. The formation of the FGF-fibroblast growth factor receptor-HS complex is necessary to activate FGF-2 signaling and induce the phosphorylation of extracellular signalregulated kinase (Erk1/2). In this study, we observed a reduction in HS 6-O-sulfation, which is critical for FGF-2 signal transduction, and failure of the FGF-2-induced phosphorylation of Erk1/2 in the aged subventricular zone. In addition, we observed increased HS 6-O-endo-sulfatase, an enzyme that may be responsible for the HS modifications in aged fractones. In conclusion, the data revealed that heparan sulfate 6-O-sulfation is reduced and FGF-2-dependent Erk1/2 signaling is impaired in the aged subventricular zone. HS modifications in fractones might play a role in the reduced neurogenic activity in aging brains.
The subventricular zone (SVZ) of the lateral ventricle is the major neurogenic niche in the adult mammalian brain (Altman 1963; Doetsch et al. 1999) . Neural stem cells (NSCs) expressing glial fibrillary acidic protein (GFAP) and Nestin (Lendahl et al. 1990; Doetsch et al. 1997) can differentiate into transit amplifying cells that in turn give rise to doublecortin (DCX)-expressing neuroblasts. These neuroblasts migrate along the rostral migratory stream toward the olfactory bulb where they mature into neurons (Lois and Alvarez-Buylla 1994; Doetsch et al. 2002) . This chain of events is regulated by multiple growth factors, including fibroblast growth factor 2 (FGF-2) (Vescovi et al. 1993) . FGF-2 promotes phosphorylation of serine/threonine kinase (Akt), extracellular signal-regulated protein kinases 1 and 2 (Erk1/2) and c-Jun N-terminal kinase (JNK) (JohnsonFarley et al. 2007; Tanabe et al. 2012) and promotes neurogenesis in the adult brain (Palmer et al. 1995; Petreanu and Alvarez-Buylla 2002) .
Mercier and colleagues previously characterized specialized extracellular matrix (ECM) structures called fractones that directly contact NSCs (Mercier et al. 2002 (Mercier et al. , 2003 . Fractones consist of ubiquitous ECM components, including laminin, collagen IV, nidogen, and the heparan sulfate proteoglycans (HSPGs) perlecan (1 : 400 rat clone A7L6, biotin, Cat# ab79465, RRID:AB_1604104; Abcam, Cambridge, UK) and agrin (Kerever et al. 2007 (Kerever et al. , 2014 . Heparan sulfates (HS) are necessary for the formation of 2 : 2 : 2 FGF-fibroblast growth factor receptor (FGFR)-HS dimers and the transduction of FGF-2 signaling (Mohammadi et al. 2005) . We have previously demonstrated that HSPGs associated with fractones sequester the growth factors FGF-2 and bone morphogenetic proteins via a heparin-binding mechanism to regulate neurogenesis in the adult SVZ (Kerever et al. 2007; Mercier and Arikawa-Hirasawa 2012; Douet et al. 2013; Mercier and Douet 2014) .
HS are selectively sulfated at the N, 3-O, and 6-O positions of N-acetylglucosamine and the 2-O position of Uronic acid (glucuronic acid and iduronic acid) residues in the Golgi apparatus. The first polymer modification is the N-deacetylation/N-sulfation of N-acetylglucosamine (GlcNAc) residues into glucosamine (GlcNS) by N-deacetylase/N-sulfotransferase enzymes. Then, HS 2-sulfotransferases catalyze the transfer of a sulfate to the C2-position of uronic acid residues. Subsequently, HS 6-sulfotransferases (HS6ST) catalyze the transfer of a sulfate to the sixth position of the N-acetylglucosamine residue in HS. HS 3-sulfotransferases transfer sulfate to the 3-OH position of glucosamine residues of HS (Sugahara and Kitagawa 2002; Kreuger and Kjell en 2012) . Finally, HSPGs are secreted in the ECM and cell surface where they are involved in growth factor storage and growth factor-induced signal transduction (Bernfield et al. 1999; Nybakken and Perrimon 2002) .
FGFRs contain three extracellular Ig-like domains (I, II, and III) (Birnbaum et al. 1991; Basilico and Moscatelli 1992) . While Domain I is not required for ligand binding and signaling, domains II and III largely regulate FGF recognition. The heparin-binding site is located in the distal portion of domain II (Kan et al. 1993) . The major site for the direct interaction between FGF and FGFR is within the membrane proximal portion of domain III (Birnbaum et al. 1991; Basilico and Moscatelli 1992) . The binding affinity of FGF-2 for FGFR depends both on the FGFR subtype and on the alternative splicing of domain III (Scotet and Houssaint 1998; Gong 2014) . 2c , and 3c have relatively higher binding affinity for FGF-2 than FGFR-1b, 2b, and 3b (Ornitz et al. 1996) .
The formation of the FGF-FGFR-HS complex and FGFR dimerization are both necessary for FGF-2 signal transduction (Amaya et al. 1991; Ueno et al. 1992; Rapraeger 1995) . Furthermore, the capacity of FGF-2 to bind FGFR is determined by different HS structures. 2-O-sulfation is necessary for the HS chain to bind to FGF-2 (Rusnati et al. 1994) and for subsequent activation of Erk1/2 signaling (Chan et al. 2015) ; on the other hand, 6-O-sulfation is necessary for FGF-2 activity through FGFR (Sugaya et al. 2008) .
HS6ST and HS 6-O-endo-sulfatase (SULF) regulate 6-Osulfation of the HS chain. HS 6-sulfotransferases add a sulfate to the sixth position of the N-acetylglucosamine residue in HS. There are three isoforms of HS6ST, HS6ST-1, -2, and -3 (Habuchi et al. 2003) . HS 6-O-endo-sulfatases are extracellular enzymes that selectively remove 6-O-sulfate groups from HS. SULF1 and SULF2 are known as isoforms of sulfate 6-O-endo-sulfatases (Morimoto-Tomita 2002). SULF1/2 regulates the interaction of numerous heparinbinding growth factors and cytokines with HS (Uchimura et al. 2006; Zhao et al. 2007) . The over-expression of SULF1/2 reduces 6-O-sulfation and down-regulates signaling pathways involved in cell proliferation, such as FGF-2, Heparin-binding epidermal growth factor-like growth factor (HB-epidermal growth factor), or hepatocyte growth factor signaling (Lai et al. 2003 (Lai et al. , 2004 . In addition, SULF1 activity has been shown to suppress FGF-2 induced phosphorylation of Erk1/2 (Wang et al. 2004) . SULF1/2 reduces Wnt binding to heparin and HS chains of Glypican 1, which promotes Wnt signaling (Ai et al. 2003) .
Neurogenesis significantly decreases as the brain ages (Maslov et al. 2004) . The number of NSCs declines in the brains of aged mice (Maslov et al. 2004; Shook et al. 2012 ). This decline is associated with decreased cell proliferation in the SVZ (Tropepe et al. 1997; Jin et al. 2003) .
We recently reported the effects of aging on ECM contents in the SVZ. The size of fractones drastically increased, while the specific motifs of HS chains changed in aged fractones. The changes in the HS chain did not affect the in situ FGF-2 binding ability of aged fractones (Kerever et al. 2015) . However, the effects of fractone-associated HS changes on neurogenesis in the aged SVZ remain unclear. We hypothesized that HS changes in aged fractones may play an important role in the reduced neurogenic activity in aging brains.
Materials and methods

Animals
In this study, young (10-12 weeks) and aged (98-100 weeks) mice were used. The Animal Care and Use Committee of Juntendo University approved all of the animal protocols. Mice were all C57BL6SVJ purchased from Jackson Laboratory. Both females and males were used for the study. However, only male mice were used for the western blot analysis and disaccharide analysis.
FGF-2 treatment assays
For FGF-2 stimulation in NSCs, the mice were intracerebroventricularly injected with FGF-2 (1 lL of 0.075 lg/ll; young, n = 4; aged, n = 4). The mice were killed 40 min after intracerebroventricular injections.
Histology
After the mice were deeply anesthetized, the brains were dissected and immersed in À40°C isopentane. Then, 25 lm-thick sections were obtained using a Leica cryostat. The sections were stored at À30°C until immunostaining.
Western blotting
The whole SVZ was carefully dissected (Kerever et al. 2015) and was lysed in ristocetin-induced platelet agglutination buffer (1% deoxycholate, 0.1% sodium dodecyl sulfate, 150 mM NaCl, 25 mM Tris-HCL, pH 8, Igepal CA630, 5 mM EDTA, protease inhibitor and phosphoSTOP; sonicated three times for 10 s). The lysates were boiled in an LDS-sample buffer (Invitrogen Corporation, Carlsbad, CA, USA) with dithiothreitol for 10 min. The samples were loaded on 4-12% polyacrylamide Bis-Tris gels (Invitrogen Corporation). After electrophoresis, the proteins were transferred to an Immobilon-P-polyvinylidene difluoride membrane (Merck Millipore, Darmstadt, Germany). The membrane was blocked with 5% polyvinylidene difluoride Blocking Reagent (TOYOBO CO, Osaka, Japan) in Tris-buffered saline-0.1% Tween 20 and incubated with the indicated antibodies. The primary antibodies used in western blotting were GFAP (RRID: AB_10013482; 1 : 3000 rabbit polyclonal, Cat# N1506; Dako, Glostrup, Denmark), Nestin (RRID:AB_2282642; 1 : 1000 chicken, Cat# NB100-1604; Novus Biologicals, Littleton, CO, USA), Hes1 (RRID:AB_177526, Cat# AB5702; 1 : 1000 rabbit polyclonal; Merck Millipore), Doublecortin (RRID:AB_2088494; 1 : 1000 goat polyclonal, Cat# sc-8066; Santa Cruz Biotechnology, Dallas, TX, USA), Sulfatase 1 (RRID:AB_882749; 1 : 1000 rabbit polyclonal, Cat# ab32763; Abcam), Sulfatase 2 (RRID: AB_10899649; 1 : 1000 rabbit polyclonal, Cat# ab101057; Abcam), beta-actin (RRID:AB_626632; 1 : 3000 mouse IgG, Cat# sc-47778; Santa Cruz Biotechnology), Akt (RRID: AB_329827; 1 : 1000 rabbit polyclonal, Cat# 9272 also 9272S; Cell Signaling, Danvers, MA, USA), phospho-Akt (RRID: AB_2315049; 1 : 1000 mouse IgG, Cat# 4060 also 4060L, 4060S, 4060P; Cell signaling), Erk1/2 (RRID:AB_330744; 1 : 1000 rabbit polyclonal, Cat# 9102 also 9102L, 9102S; Cell Signaling), phospho-Erk1/2 (RRID:AB_331646; 1 : 1000 rabbit polyclonal, Cat# 9101 also 9101S, 9101L; Cell Signaling), GSK3-b (RRID:AB_490890; 1 : 1000 rabbit polyclonal, Cat# 9315 also 9315S, 9315L, 9315P; Cell Signaling), phospho-GSK3-b (RRID: AB_2115201; 1 : 1000 rabbit polyclonal, Cat# 9323 also 9323S, 9323P; Cell Signaling), and phospho-JNK (RRID:AB_331659; 1 : 1000 rabbit polyclonal, Cat# 9251 also 9251L, 9251S; Cell Signaling). The secondary antibodies were rabbit IgG-horseradish peroxidase (HRP) (1 : 1000; Amersham Pharmacia Biotech, Piscataway, NJ, USA), goat IgG-HRP (1 : 1000; Abcam), mouse IgG-HRP (1 : 1000; Amersham), and chicken IgG-HRP (1 : 2000; Abcam). The SuperSignal West Dura Chemiluminescent Substrate (Thermo Scientific, Rockford, IL, USA) was used to detect proteins.
Immunofluorescence
Sections were post-fixed in cold paraformaldehyde for 10 min and washed in phosphate-buffered saline (PBS). The sections were then placed in a 0.5% Triton X-100/PBS solution for 15 min followed by 15 min of a blocking solution (0.2% gelatin/PBS). The primary antibodies were applied for either 2 h at room temperature or overnight at 4°C in blocking solution. The following primary antibody dilutions were used: GFAP (RRID:AB_10013482; 1 : 1000 rabbit; Dako), DCX (RRID:AB_2088494; 1 : 200 goat; Santa Cruz Biotechnology), laminin (RRID:AB_477163; 1 : 1000 rabbit polyclonal Cat# L9393; Sigma Aldrich, St. Louis, Missouri, United States), heparan sulfate (RRID:AB_10013601; epitope 10e4 1 : 400 mouse IgM; US Biological Salem, MA 01970, USA). To reveal FGF-2 binding, recombinant human FGF-2 protein (Peprotech, Rocky Hill, NJ, USA) was linked to a fluorescent tag using the Dylight-650 labeling kit from Pierce (Thermo Scientific). The sections were then rinsed, and the secondary antibodies were applied for 40 min at 25°C. The following fluorochrome-conjugated secondary antibody dilutions were used: donkey anti-goat-FITC (1 : 400; Jackson ImmunoResearch Laboratories, West Grove, PA, USA), streptavidin-546 (1 : 400; Life Technologies, Grand Island, NY, USA), goat anti-chicken Alexa Fluor-594 (1 : 400; Life Technologies), goat anti-rabbit Alexa Fluor-488 (1 : 400; Life Technologies). The sections were rinsed and incubated for 10 min in bis-benzimide (1 : 3000; Molecular Probes, Eugene, OR, USA). After extensive washing, the sections were mounted in fluoro-gel with Tris buffer (Electron Microscopy Sciences, Hatfield, PA, USA).
Image acquisition was performed using a LSM780 (Zeiss, Oberkochen, Germany) microscope. Confocal images represent the maximum intensity projection of a stack of 11 images taken with a step size of 1 lm in the z-axis.
Quantitative real-time PCR RNA from whole SVZ (caudate putamen side) was extracted using TRIzol reagent (Invitrogen). The cDNA was synthetized using the RT 2 First strand kit from Qiagen, Valencia, CA, USA. Real-time PCR was performed using KAPA SYBR FAST qPCR MasterMix and ROX High on a Fast 7500 Real Time Cycler (Applied Biosystems, Foster City, California, United States). Beta-actin and GAPDH were used as endogenous controls. The primers that were used are shown in Table 1 .
Disaccharide analysis
Actinase E was purchased from Kaken Pharmaceutical Co., Ltd., Tokyo, Japan. Heparinase I, Heparinase II, Heparinase III from Flavobacterium heparinum, unsaturated disaccharides of HS (ΔUA-GlcNAc, ΔUA-GlcNS, ΔUA-GlcNAc6S, ΔUA-GlcNS6S, ΔUA2S-GlcNS, ΔUA2S-GlcNS6S) were purchased from Seikagaku Corp., Tokyo, Japan. Microscale isolation of glycosaminoglycans (GAGs) was performed using an anion exchange spin column with minor modifications (Imamura et al. 2016 ). Brain tissues were lyophilized until they were dry. Dried samples (1-3 mg) were defatted by treatment with 1 mL of acetone and then treated with actinase E (0.25 mg/ mL) in 400 lL of 50 mM Tris-acetate buffer (pH 8.0) at 45°C for 2 days. After dissolving the peptides with dry ceramide heptasaccharide(CHPS) and urea (2% CHPS and 8 M urea), particulates were removed by a Millex-LH Syringe-driven Filter Unit (Millipore Corporation, Bedford, MA, USA). The filtrated extract was purified in a Vivapure Q mini H spin column (Sartorius Stedim Biotech, Aubagne, France) by centrifugation at 1800 g. The column was washed three times with 500 lL of 0.2 M NaCl. GAGs were then eluted from the column by washing it two times with 500 lL of 16% NaCl. The GAGs were precipitated by adding 4 mL of cold methanol for 16 h at 4°C and were recovered by centrifugation at 11 000 g for 30 min. Whole GAG samples were incubated in 16 lL of reaction mixture (pH 7.0) containing 1 mIU heparinase I, 1 mIU heparinase II, 1 mIU heparinase III, 31.3 mM sodium acetate, and 3.13 mM calcium acetate for 16 h at 37°C. After boiling, the samples were purified by an Amicon Ultra Centrifugal Filter (10 000 molecular weight cut off: Millipore Corporation, Bedford, MA, USA) by centrifugation at 15 000 g. Then, HS disaccharides were collected from the under layer and lyophilized before they were resuspended in 10 lL of water.
Unsaturated disaccharide analysis was conducted with reverse phase ion-pair chromatography using sensitive and specific postcolumn detection (Imamura et al. 2016) .
The HPLC system was constructed with high-pressure pump (LC10Ai; Shimadzu, Kyoto, Japan), Intelligent Fluorescence detector (FP-920S; Jasco, Tokyo, Japan), a dry reaction bath (DB-3; Shimamura instruments co., Tokyo, Japan), double plunger pumps for reagent solution (NP-FX (II)-1U; Nihon Seimitsu Kagaku Co. Ltd., Tokyo, Japan), an Autosampler (L-7200; Hitachi HighTechnologies Corp., Tokyo, Japan), and Chromato-PRO data processing software (Run Time Corporation, Tokyo, Japan). A gradient was applied at a flow rate of 1.0 mL/min on Senshu Pak Docosil (4.6 9 150 mm; Senshu Scientific, Tokyo, Japan) at 60°C. The eluent buffers were as follows: A, 10 mM tetra-nbutylammonium hydrogen sulfate in 12% methanol; B, 0.2 M NaCl in buffer A. The gradient program was as follows: 0-10 min (1-4% B), 10-11 min (4-15% B), 11-20 min (15-25% B), 20-22 min (25-53% B), and 22-29 min (53% B). Aqueous (0.5% (w/v)) 2-cyanoacetamide solution and 1 M NaOH were added to the eluent at the same flow rates (0.5 mL/min) using a double plunger pump. The effluent was monitored fluorometrically (excitation, 346 nm; emission, 410 nm).
Quantification and statistical analyses
Western blot and disaccharide data analyses were performed by an experimenter blinded to the experimental conditions but other analysis were not. No formal power calculation was performed instead, the sample size in each experiment was determined based on our previous studies and publications from others (Jin et al. 2003; Kerever et al. 2014) . Statistical data are presented as means AE SEMs and were analyzed using the unpaired Student's ttest with confidence intervals of 99% or ANOVAs with Bonferroni's multiple comparison test. (Graph-Pad Prism version 6.0 for Mac OS X; Graph-Pad Software, San Diego, CA, USA).
Results
Cellular composition in the SVZ changes with aging
In this study, we investigated the cellular composition surrounding the fractones. Using the whole SVZ located on the surface of the caudate nucleus, we performed an immunoblot analysis. Nestin expression was significantly decreased in the aged SVZ (Fig. 1a and b) . The expression level of the neuroblast marker DCX was also significantly decreased in the aged SVZ (Fig. 1a and c) . In contrast, GFAP expression significantly increased with aging ( Fig. 1a  and d) . The cellular composition drastically differs in the aged SVZ compared to the young SVZ. Neurogenesis decreases in the aged SVZ Next, we investigated neurogenesis in the young and aged SVZ. The DCX + area in the region of interest was decreased in the aged SVZ ( Fig. 2a and b) . In contrast, the GFAP + area in the region of interest remained unchanged in the young and aged SVZ (Fig. 2c) . Therefore, the GFAP/DCX ratio increased in the aged SVZ (Fig. 2d) . Thus, the number of neuroblasts decreased while the number of astrocytes was consistent in the aged SVZ. Then, we quantified the expression of the transcription factor Hes1, which negatively regulates neuronal differentiation when it is over-expressed (Ishibashi et al. 1994; Ohtsuka et al. 2001) . Hes1 expression levels were significantly increased in the aged SVZ (Fig. 2e  and f) . This result also indicates that neurogenesis decreases in the aged SVZ.
FGF-2 binds to fractones in vivo in the aged brain
We previously showed that FGF-2 binds HS chains contained in fractones in young adult brains in vivo (Kerever et al. 2007; Douet et al. 2013) . To further investigate the role of fractones in the aged neurogenic niche, we investigated the binding ability of FGF-2 to HS chains in vivo with young and aged brains. We injected fluorescently-labeled FGF-2 into the ventricles of young and aged mice. FGF-2 was captured by HS chains contained in fractones both in the young and aged SVZ (Fig. 3) . Thus, aged fractones were able to capture FGF-2 in the aged SVZ.
FGF-2 did not promote the phosphorylation of Erk1/2 in the aged SVZ To understand the effects of FGF-2 treatment in the young and aged SVZ, we investigated FGF-2 downstream signaling in vivo by injecting FGF-2 into the brain and measuring downstream signaling within 40 min. First, the basal phosphorylation level of Akt, GSK3-b, and JNK remain constant with aging ( Fig. 4a and b) . However, the basal phosphorylation level of Erk1/2 significantly increases with aging ( Fig. 4a and b) . In our study, FGF-2 promoted the phosphorylation of Akt, GSK3-b, JNK, and Erk1/2 signaling in the young SVZ (Fig. 4a and c) . In the aged SVZ, FGF-2 treatment resulted in the phosphorylation of Akt, GSK3-b, and JNK signaling (Fig. 4a and c) . However, FGF-2 failed to promote the phosphorylation of Erk1/2 (Fig. 4a and c) . Together, these results indicate that FGF-2-dependent Erk1/2 signaling was impaired in the aged SVZ.
FGFR1, 2, and 3 isoform expression changes with aging FGF-2 displayed different affinities for FGFR isoforms. To determine whether a change in the FGFR isoform could explain the failure of FGF-2 to promote the phosphorylation of Erk1/2, we quantified the mRNA expression of FGFR splice variants in young and aged SVZ. The expression levels of the low affinity FGFR-1b and FGFR-2b were significantly decreased, while the expression levels of the high affinity FGFR-1c, FGFR-2c, and FGFR-3c were significantly increased in the aged SVZ (Table 2) .
6-O-sulfation of HSPG was impaired in the aged SVZ HSPG modifications in aged fractones may impair FGFR and FGF-2 interactions. To understand the impairment of FGF-2 signaling in the aged SVZ, we performed disaccharide composition analysis of HS in young and aged SVZ. The composition of total 6-O-sulfation significantly decreased with aging (Fig. 5b) . In addition, there was a significant decrease in HS level in the aged SVZ. To further investigate Fig. 3 In vivo fibroblast growth factor 2 (FGF-2) binding in young and aged subventricular zone (SVZ). The confocal image is showing the same location as Fig. 2(b) . Young and aged mice were intracerebroventricular-injected with 0.5 lg of FGF-2 three hours prior to killing. A confocal image shows the ipsilateral side of the lateral ventricle after injection of fluorescently-labeled FGF-2. Fractones and blood vessels are labeled with laminin and 10e4. We detected FGF-2 binding on the fractone (arrow) both in young and aged SVZ in vivo. Scale bar in the left panels = 25 lm. Scale bar in other panels = 10 lm. the mechanism of 6-O-sulfation impairment in the aged SVZ, we studied sulfotransferase mRNA expression. The expression level of 6-O-sulfotransferase-2 (HS6ST2) mRNA was significantly decreased in the aged SVZ (À0.607 AE 0.192, pvalue: 0.002). The mRNA expression levels of other sulfotransferases HS 2-sulfotransferases 1, HS6ST1, and HS6ST3 did not change. Finally, the expression levels of HS 6-O-endo-sulfatases, SULF1 and SULF2, in young and aged SVZ were investigated by immunoblot analysis. The expression levels of SULF1 and SULF2 were significantly increased in the aged SVZ (Figs. 6a-c) .
Discussion
The results obtained in this study support three major conclusions. First, FGF-2 signaling in neurogenesis was impaired in the aged SVZ. Second, modifications in the HS chains were correlated with the impaired FGF-2 signaling in FGF-2 induced a significant increase in the activation of Akt, GSK3-b, JNK, and Erk1/2 pathways in young mice. FGF-2 significantly induced the activation of the Akt, GSK3-b, and JNK pathways in the SVZ of aged mice, but not the activation of Erk1/2 pathway. The data are expressed as means AE SEM (n = 4 mice, **p < 0.005 and ***p < 0.0005; ANOVA). the aged SVZ. Third, higher expression of SULF1/2 enzymes may result in HS chain modifications in aged fractones.
Neurogenesis and FGF-2 signaling in the aged brain Neurogenesis is critical for the maintenance of brain structures and functions in the adult mouse brain (Zhao et al. 2008) . Decreased neurogenesis in the hippocampus impairs memory and learning capabilities (Zhao et al. 2003) .
Decreased neurogenesis in the SVZ impairs olfactory sensitivity and discrimination capabilities (Enwere et al. 2004) . First, we investigated the cellular composition of and neurogenesis in the SVZs from both young and aged mice. Nestin expression was decreased in the aged SVZ (Fig. 1a  and c) , which suggests a decreased number of NSCs (Maslov et al. 2004) . Furthermore, we observed decreased DCXexpressing neuroblasts (Figs 1a, c and 2b) , which also indicates decreased neurogenesis in the aged SVZ (Tropepe et al. 1997; Maslov et al. 2004) . Although GFAP expression levels increased in the aged SVZ (Fig. 1a and d) , GFAP expression levels remained unchanged in the vicinity of the ventricle (Fig. 2a and c) . These results suggest there was an increase in the number of astrocytes or astrocyte processes in the distal area of the ventricle. Furthermore, the high expression of Hes1 observed in the aged SVZ ( Fig. 2e and f) may have inhibited neural differentiation (Ishibashi et al. 1994; Ohtsuka et al. 2001) . Altogether, the number of NSCs and neuroblasts were decreased in the aged SVZ.
We first investigated FGF-2 signaling to understand the age-related changes in neurogenesis and cellular composition of the SVZ. FGF-2 is released by choroid plexus epithelial The disaccharide composition of total 6-O-sulfation was significantly decreased in aged SVZ samples. (n = 16 mice, young SVZ total 6S%: 13.56 AE 1.074 SEM; aged SVZ total 6S%: 11.09 AE 0.892 SEM; *p < 0.05; unpaired student's t-test).
cells into the CSF, which travels though the interstitial clefts between the ependymal walls (Brightman 2002) to be captured by fractones localized at the ends of the interstitial clefts (Kerever et al. 2007 ). FGF-2 was detected exclusively in fractones in both young and aged SVZs (Fig. 3) .
To understand the mechanism of decreased neurogenesis, we investigated FGF-2 signaling in vivo and found that FGF-2 dependent phosphorylation of Erk1/2 is significantly reduced in the aged SVZ (Fig. 4a and c) .
Interactions between FGF, FGFR, and HS structures It is known that FGF-FGFR-HS ternary complex is critical for FGF-2-induced activation of Erk1/2 signaling pathway. Then we investigated the interaction between each partner of the ternary complex in the aged SVZ.
First, we investigated the expression levels and splicing patterns of FGFRs to investigate whether FGF-2/FGFR affinity was responsible for the impaired FGF-2 signaling. The major site for the direct interaction of FGF/FGFR in domain III is subject to splicing variation. The binding affinity of FGF-2 and FGFRs depends on the splicing variation in the FGFRs. FGFR-1c, 2c, and 3c have a relatively higher ligand affinity for FGF-2 than that of FGFR-1b, 2b, and 3b (Ornitz et al. 1996) . The increased expression of the high affinity FGFR isoforms for FGF2 (Table 1) suggests that the changes in alternative splicing patterns of FGFRs were not responsible for the impairment of FGF-2 signaling in the aged SVZ. Rather, the alternative splicing patterns may be the result of FGFR autoregulation as a biological response to impaired FGF-2 signaling and could be a possible explanation for the basal elevation of Erk1/2 phosphorylation. Second, we investigated whether FGF-2/HS chain interaction was changed in the aged SVZ. FGF-2/HS chain binding was similarly observed in both young and aged fractones (Fig. 3) . It is reported that 2-O-sulfation is necessary for the HS chain to bind to FGF-2 (Rusnati et al. 1994) and promote subsequent activation of Erk1/2 signaling (Chan et al. 2015) . In our HS chain composition analysis, 2-O-sulfation was not significantly modified with aging (Fig. 5b) . These results supported that FGF-2/HS chain binding was sustained in the aged brain.
Third, we investigated whether FGFR/HS chain interactions were responsible for impaired FGF-2 signaling. The promotion of FGF-2 signaling through FGFR was determined by HS structures. The 6-O-sulfation was involved in a direct interaction between heparin and FGFRs (Rusnati et al. 1994; Sugaya et al. 2008) . Total 6-O-sulfation decreased in the aged SVZ (Fig. 5b) . Decreased 6-O-sulfation might be responsible for the impairment of FGF-2-dependent Erk1/2 signaling in the aged SVZ. In the SVZ of young mice, the fibroblast growth factor (FGF)-fibroblast growth factor receptor (FGFR)-heparan sulfate (HS) complex is formed and FGFR is dimerized. Therefore, FGF-2 promotes ERK phosphorylation. In the SVZ of aged mice, the over-expression of SULF1/2 enzymes may account for 6-O-sulfation decreases in HS leading to impaired FGF-2-dependent Erk1/2 signaling.
SULF1/2 and modifications of the HS chain
We investigated the mechanism of how 6-O-sulfation decreases in the aged SVZ. We hypothesized that decreased sulfation may be because of either a decrease in HS 6-sulfotransferases and/or an increase in HS 6-O-endo-sulfatases.
mRNA expression of HS6ST1 and HS6ST3 remained constant throughout aging, while the expression of HS6ST2 decreased in the aged SVZ (Table 1 ). This outcome suggests that the decline of HS6ST2 expression may participate in the decrease in HSPG 6-O-sulfation in the aged fractone. However, in a previous study, the mRNA expression levels of sulfotransferases did not correlate with HS chain composition (Nairn et al. 2007) .
HS 6-O-endo-sulfatases, SULF1 and SULF2, selectively remove 6-O-sulfate groups from HS both in the Golgi and extracellularly (Morimoto-Tomita 2002) . The high expression of SULF1/2 (Fig. 6a-c ) may have caused a 6-Osulfation decrease and resulted in the impairment of FGF-2 signaling in the aged SVZ ( Fig. 6a and b) . A loss of immunoreactivity of the 10e4 antibody has previously been shown to result from 6-O-endo-sulfatase activity in vitro (Ai et al. 2003) . Interestingly, our previous results demonstrated that the immunoreactivity of the 10e4 antibody decreased in the aged fractones (Kerever et al. 2015) . In this study, SULF1/2 significantly increased in the aged SVZ. Therefore, we propose that increased SULF1/2 may participate in the 6-O-sulfation decrease in the aged fractone HS chain (leading to the loss of 10e4 immunoreactivity).
In conclusion, SULF1/2-related 6-O-sulfation decreases in the aged HS chains might impair FGF-2-dependent Erk1/2 signaling in the aged SVZ (Fig. 6d) .
